Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2017-04-05 2017-04-05
Drug Identification Number 02246026 02246026
Brand name PEGETRON PEGETRON
Common or Proper name ribavirin plus peginterferon alfa-2b, Powder for Solution in Vials ribavirin plus peginterferon alfa-2b, Powder for Solution in Vials
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients RIBAVIRIN PEGINTERFERON ALFA-2B RIBAVIRIN PEGINTERFERON ALFA-2B
Strength(s) 200MG 50MCG 200MG 50MCG
Dosage form(s) CAPSULE POWDER FOR SOLUTION CAPSULE POWDER FOR SOLUTION
Route of administration ORAL SUBCUTANEOUS ORAL SUBCUTANEOUS
Packaging size vial vial
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-04-04 2017-04-04
Actual discontinuation date 2017-04-04 2017-04-04
Remaining supply date 2017-04-04 2017-04-04
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments